XML 40 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share (Tables)
6 Months Ended
Dec. 31, 2017
Earnings Per Share [Abstract]  
Reconciliation of Numerators and Denominators Used in Basic and Diluted Earnings Per Common Share Computations
The following table presents a reconciliation of the numerators and denominators used in the basic and diluted earnings per common share computations (in thousands except share and per share amounts):
 
Three Months Ended 
 December 31,
 
Six Months Ended 
 December 31,
 
2017
 
2016
 
2017
 
2016
Numerator
 
 
 
 
 
 
 
Net income (loss)
$
(413
)
 
$
1,043

 
$
(2,390
)
 
$
(815
)
Income allocated to participating securities

 
(18
)
 

 

Net income (loss) available to common stockholders
$
(413
)
 
$
1,025

 
$
(2,390
)
 
$
(815
)
Denominator
 
 
 
 
 
 
 
Weighted average common shares outstanding – basic
33,112,138

 
32,189,981

 
33,040,425

 
32,060,973

Effect of dilutive stock options(1)

 
111,874

 

 

Effect of dilutive restricted stock units(2)

 
313,820

 

 

Effect of performance-based restricted stock awards(3)

 
188,630

 

 

Weighted average common shares outstanding – diluted
33,112,138

 
32,804,305

 
33,040,425

 
32,060,973

 
 
 
 
 
 
 
 
Earnings per common share – basic
$
(0.01
)
 
$
0.03

 
$
(0.07
)
 
$
(0.03
)
Earnings per common share – diluted
$
(0.01
)
 
$
0.03

 
$
(0.07
)
 
$
(0.03
)


(1)
At December 31, 2017 and 2016, 22,321 and 181,040 stock options were outstanding, respectively. The effect of the shares that would be issued upon exercise of these options has been excluded from the calculation of diluted loss per share, for the three and six months ended December 31, 2017 and six months ended December 31, 2016, because those shares are anti-dilutive.
(2)
At December 31, 2017 and 2016, 335,869 and 350,771 additional shares of common stock, respectively, were issuable upon the settlement of outstanding restricted stock units. The effect of the shares that would be issued upon settlement of these restricted stock units has been excluded from the calculation of diluted loss per share, for the three and six months ended December 31, 2017 and six months ended December 31, 2016, because those shares are anti-dilutive.
(3)
At December 31, 2017 and 2016, 585,832 and 336,826 performance-based restricted stock awards, respectively, were outstanding. The effect of the shares that would be issued upon vesting of these awards has been excluded from the calculation of diluted loss per share, for the three and six months ended December 31, 2017 and six months ended December 31, 2016, because those shares are anti-dilutive.